Specifications

 Technical parameter:

1.) Laser medium : GaAlAs Semiconductor 

2.) Laser wavelength: 650nm

3.) Terminate laser medium quantity : 6pcs.

4.) single laser medium terminate output voltage :≤5mw

5.) Terminate output laser control :3 grade for adjustment. 

6.) Fixed time range: 10 minutes to 60minutes, and six grade for adjustment.

7.) Battery voltage: 3.7 to 4.2V

8.) Lithium ion battery output voltage:5.5V

9.) Instrument power consumption:<1 W

10.) Environment temperature:5°C-40°C

11.)Relative humidity: ≤80%

Application Range:

Hyperviscosity, hyperlipemia, hyperlipidemia, hypertension, diabetes, ischemic heart and cerebral vascular disease caused by cardiovascular and cerebrovascular diseases. It`s also has good curative on the Rhinitis, allergic rhinitis, acute rhinitis, chronic rhinitis, sinusitis and nasal polyps.

Therapeutic Principle:

Our Semiconductor Laser Therapeutic Instrument has been developed base on modern laser medicine and clinical practice. It adopts low-level laser with the wavelength of 650nm, through specific parts of irradiation and using light radiation of laser and wavelength relation to change the biological characteristics and peel off the fat layer and cholesterol wrapped in the red blood cells, to improve the activity and oxygen carrying capacity as well as the deformability of cells, reduce the concentration of middle molecules in the blood, improve hem rheological properties and lower triglycerides and cholesterol, in order to effectively treat and prevent heat and brain diseases.

Function and Performance:

1)Improving blood viscosity through laser blood irradiation.

2)Improving blood oxygen carrying capacity through laser blood irradiation.

3)Reducing blood-fat and total cholesterol through laser blood irradiation.

4)Quickly and effectively correct the abnormity of lipid metabolism and maintain the equilibrium level of the lipid metabolism in the human body through laser blood irradiation.

5)Improving the partial blood circulation around the nasal cavities and the immunological competence of the nasal mucosa membranes through irradiation the nasal mucosa.

6)Therapeutic efficacy control on ischemic cardio-cerebrovascular diseases.